Global Medical Cannabis Market Overview:
Global Medical Cannabis Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Medical Cannabis Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Medical Cannabis involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Medical Cannabis Market:
The Medical Cannabis Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Medical Cannabis Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Medical Cannabis Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Medical Cannabis market has been segmented into:
Solids
Dissolvable/ Powders
Oil
and Ointments & Creams
By Application, Medical Cannabis market has been segmented into:
Cannabidiol and Tetrahydrocannabinol
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Medical Cannabis market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Medical Cannabis market.
Top Key Players Covered in Medical Cannabis market are:
Canopy Growth Corporation (Canada)
Cannabis Sativa Inc. (US)
GW Pharmaceuticals plc (UK)
Emerald Health Therapeutics (Canada)
Tilray Inc. (Canada)
Aurora Cannabis Inc. (Canada)
Cara Therapeutics (US)
Medical Marijuana Inc. (US)
GB Sciences Inc. (US)
Canndoc (Israel)
among others
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Medical Cannabis Market Type
4.1 Medical Cannabis Market Snapshot and Growth Engine
4.2 Medical Cannabis Market Overview
4.3 Solids
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Solids: Geographic Segmentation Analysis
4.4 Dissolvable/ Powders
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Dissolvable/ Powders: Geographic Segmentation Analysis
4.5 Oil
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Oil: Geographic Segmentation Analysis
4.6 and Ointments & Creams
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 and Ointments & Creams: Geographic Segmentation Analysis
Chapter 5: Medical Cannabis Market Application
5.1 Medical Cannabis Market Snapshot and Growth Engine
5.2 Medical Cannabis Market Overview
5.3 Cannabidiol and Tetrahydrocannabinol
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Cannabidiol and Tetrahydrocannabinol: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Medical Cannabis Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 CANOPY GROWTH CORPORATION (CANADA)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 CANNABIS SATIVA INC. (US)
6.4 GW PHARMACEUTICALS PLC (UK)
6.5 EMERALD HEALTH THERAPEUTICS (CANADA)
6.6 TILRAY INC. (CANADA)
6.7 AURORA CANNABIS INC. (CANADA)
6.8 CARA THERAPEUTICS (US)
6.9 MEDICAL MARIJUANA INC. (US)
6.10 GB SCIENCES INC. (US)
6.11 CANNDOC (ISRAEL)
6.12 AMONG OTHERS
Chapter 7: Global Medical Cannabis Market By Region
7.1 Overview
7.2. North America Medical Cannabis Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Solids
7.2.2.2 Dissolvable/ Powders
7.2.2.3 Oil
7.2.2.4 and Ointments & Creams
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Cannabidiol and Tetrahydrocannabinol
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Medical Cannabis Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Solids
7.3.2.2 Dissolvable/ Powders
7.3.2.3 Oil
7.3.2.4 and Ointments & Creams
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Cannabidiol and Tetrahydrocannabinol
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Medical Cannabis Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Solids
7.4.2.2 Dissolvable/ Powders
7.4.2.3 Oil
7.4.2.4 and Ointments & Creams
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Cannabidiol and Tetrahydrocannabinol
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Medical Cannabis Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Solids
7.5.2.2 Dissolvable/ Powders
7.5.2.3 Oil
7.5.2.4 and Ointments & Creams
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Cannabidiol and Tetrahydrocannabinol
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Medical Cannabis Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Solids
7.6.2.2 Dissolvable/ Powders
7.6.2.3 Oil
7.6.2.4 and Ointments & Creams
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Cannabidiol and Tetrahydrocannabinol
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Medical Cannabis Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Solids
7.7.2.2 Dissolvable/ Powders
7.7.2.3 Oil
7.7.2.4 and Ointments & Creams
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Cannabidiol and Tetrahydrocannabinol
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Medical Cannabis Scope:
|
Report Data
|
Medical Cannabis Market
|
|
Medical Cannabis Market Size in 2025
|
USD XX million
|
|
Medical Cannabis CAGR 2025 - 2032
|
XX%
|
|
Medical Cannabis Base Year
|
2024
|
|
Medical Cannabis Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Canopy Growth Corporation (Canada), Cannabis Sativa Inc. (US), GW Pharmaceuticals plc (UK), Emerald Health Therapeutics (Canada), Tilray Inc. (Canada), Aurora Cannabis Inc. (Canada), Cara Therapeutics (US), Medical Marijuana Inc. (US), GB Sciences Inc. (US), Canndoc (Israel), among others.
|
|
Key Segments
|
By Type
Solids
Dissolvable/ Powders
Oil
and Ointments & Creams
By Applications
Cannabidiol and Tetrahydrocannabinol
|
